相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MEK inhibitor resistance mechanisms and recent developments in combination trials
E. Kun et al.
CANCER TREATMENT REVIEWS (2021)
ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma
Ivana Yen et al.
NATURE (2021)
Clinical Acquired Resistance to KRASG12C Inhibition through a novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS-MAPK Reactivation
Noritaka Tanaka et al.
CANCER DISCOVERY (2021)
Chemoprevention of pancreatic cancer by inhibition of glutathione-S transferase P1
Takahiro Kogawa et al.
INVESTIGATIONAL NEW DRUGS (2021)
Acquired Resistance to KRASG12C Inhibition in Cancer
M. M. Awad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Vertical Pathway Inhibition Overcomes Adaptive Feedback Resistance to KRASG12C Inhibition
Meagan B. Ryan et al.
CLINICAL CANCER RESEARCH (2020)
The KRAS(G12C) Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients
Jill Hallin et al.
CANCER DISCOVERY (2020)
GSTP1 and cancer: Expression, methylation, polymorphisms and signaling (Review)
Jian Cui et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2020)
A CRAF/glutathione-S-transferase P1 complex sustains autocrine growth of cancers with KRAS and BRAF mutations
Yoshiro Niitsu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors
David S. Hong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Inhibitors of BRAF dimers using an allosteric site
Xiomaris M. Cotto-Rios et al.
NATURE COMMUNICATIONS (2020)
Recent advances in the development of protein-protein interactions modulators: mechanisms and clinical trials
Haiying Lu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Diverse Mechanisms of BRAF Inhibitor Resistance in Melanoma Identified in Clinical and Preclinical Studies
Stephen A. Luebker et al.
FRONTIERS IN ONCOLOGY (2019)
Glutathione Transferase P1-1 an Enzyme Useful in Biomedicine and as Biomarker in Clinical Practice and in Environmental Pollution
Alessio Bocedi et al.
NUTRIENTS (2019)
GSTP1 methylation in cancer: a liquid biopsy biomarker?
Giorgia Gurioli et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
Structural and Biochemical Analyses Reveal the Mechanism of Glutathione S-Transferase Pi 1 Inhibition by the Anti-cancer Compound Piperlongumine
Wayne Harshbarger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Relaxation oscillations and hierarchy of feedbacks in MAPK signaling
Marek Kochanczyk et al.
SCIENTIFIC REPORTS (2017)
Mechanisms of Acquired Resistance to BRAF V600E Inhibition in Colon Cancers Converge on RAF Dimerization and Are Sensitive to Its Inhibition
Rona Yaeger et al.
CANCER RESEARCH (2017)
Potent anti-proliferative actions of a non-diuretic glucosamine derivative of ethacrynic acid
Surendra R. Punganuru et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Negative feedback regulation of the ERK1/2 MAPK pathway
David Lake et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
GSTP1 Methylation and Protein Expression in Prostate Cancer: Diagnostic Implications
Filippo Martignano et al.
DISEASE MARKERS (2016)
Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism
Piro Lito et al.
SCIENCE (2016)
Oncogenic BRAF Deletions That Function as Homodimers and Are Sensitive to Inhibition by RAF Dimer Inhibitor LY3009120
Shih-Hsun Chen et al.
CANCER DISCOVERY (2016)
GSTP1 Is a Driver of Triple-Negative Breast Cancer Cell Metabolism and Pathogenicity
Sharon M. Louie et al.
Cell Chemical Biology (2016)
A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib
Grazia Graziani et al.
BIOCHEMICAL PHARMACOLOGY (2015)
Ezatiostat hydrochloride for the treatment of myelodysplastic syndromes
Daruka Mahadevan et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2015)
Correlation between promoter methylation in the GSTP1 gene and hepatocellular carcinoma development: a meta-analysis
Q. F. Li et al.
GENETICS AND MOLECULAR RESEARCH (2015)
Phosphorylation of Glutathione S-Transferase P1 (GSTP1) by Epidermal Growth Factor Receptor (EGFR) Promotes Formation of the GSTP1-c-Jun N-terminal kinase (JNK) Complex and Suppresses JNK Downstream Signaling and Apoptosis in Brain Tumor Cells
Tatsunori Okamura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Cytoprotective and regulatory functions of glutathione S-transferases in cancer cell proliferation and cell death
Simendra Singh
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
A small molecule that induces reactive oxygen species via cellular glutathione depletion
Tatsuro Kawamura et al.
BIOCHEMICAL JOURNAL (2014)
Stem cells and the impact of ROS signaling
Carolina L. Bigarella et al.
DEVELOPMENT (2014)
Functional interaction of glutathione S-transferase pi and peroxiredoxin 6 in intact cells
Suiping Zhou et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
Dabrafenib; Preclinical Characterization, Increased Efficacy when Combined with Trametinib, while BRAF/MEK Tool Combination Reduced Skin Lesions
Alastair J. King et al.
PLOS ONE (2013)
Glutathione-S-Transferases As Determinants of Cell Survival and Death
Kenneth D. Tew et al.
ANTIOXIDANTS & REDOX SIGNALING (2012)
Targeting GSTP1-1 induces JNK activation and leads to apoptosis in cisplatin-sensitive and -resistant human osteosarcoma cell lines
Andrea Sau et al.
MOLECULAR BIOSYSTEMS (2012)
Randomized Double-Blind Trial of Sulindac and Etodolac to Eradicate Aberrant Crypt Foci and to Prevent Sporadic Colorectal Polyps
Tetsuji Takayama et al.
CLINICAL CANCER RESEARCH (2011)
Glutathione transferases: a structural perspective
Aaron Oakley
DRUG METABOLISM REVIEWS (2011)
The role of glutathione S-transferase P in signaling pathways and S-glutathionylation in cancer
Kenneth D. Tew et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Randomized Phase III Study of Canfosfamide in Combination With Pegylated Liposomal Doxorubicin Compared With Pegylated Liposomal Doxorubicin Alone in Platinum-Resistant Ovarian Cancer
Ignace Vergote et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2010)
Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer
John J. Kavanagh et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2010)
Suppressive effect of sulindac on branch duct-intraductal papillary mucinous neoplasms
Tsuyoshi Hayashi et al.
JOURNAL OF GASTROENTEROLOGY (2009)
Glutathione S-transferase Pi mediates proliferation of androgen-independent prostate cancer cells
Naomi Hokaiwado et al.
CARCINOGENESIS (2008)
Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone
Yasushi Sato et al.
NATURE BIOTECHNOLOGY (2008)
Glutathione transferase π plays a critical role in the development of lung carcinogenesis following exposure to tobacco-related carcinogens and urethane
Kenneth J. Ritchie et al.
CANCER RESEARCH (2007)
GSTP1 promoter hypermethylation is an early event in breast carcinogenesis
Ji Shin Lee
VIRCHOWS ARCHIV (2007)
Human glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2-ASK1 signals
Y. Wu et al.
ONCOGENE (2006)
Synthesis and characterization of platinum(IV) anticancer drugs with functionalized aromatic carboxylate ligands: Influence of the ligands on drug efficacies and uptake
WH Ang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Glutathione S-transferase π1 promotes tumorigenicity in HCT116 human colon cancer cells
DT Dang et al.
CANCER RESEARCH (2005)
Regulation of raf-1 by direct feedback phosphorylation
MK Dougherty et al.
MOLECULAR CELL (2005)
Plasma glutathione S-transferase P1-1 as a prognostic factor in patients with advanced non-Hodgkin's lymphoma (stages III and IV)
T Katahira et al.
CLINICAL CANCER RESEARCH (2004)
The role of glutathione-S-transferase in anti-cancer drug resistance
DM Townsend et al.
ONCOGENE (2003)
Reversal of multiple drug resistance in cholangiocarcinoma by the glutathione S-transferase-π-specific inhibitor O1-hexadecyl-γ-glutamyl-S-benzylcysteinyl-D-phenylglycine ethylester
T Nakajima et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia
T Matsunaga et al.
NATURE MEDICINE (2003)
Glutathione S-transferase-π overexpression is closely associated with K-ras mutation during human colon carcinogenesis
K Miyanishi et al.
GASTROENTEROLOGY (2001)
Analysis of K-ras, APC, and β-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis
T Takayama et al.
GASTROENTEROLOGY (2001)
Fanconi anemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1
RC Cumming et al.
NATURE MEDICINE (2001)
分享论文
